高级检索
当前位置: 首页 > 详情页

Time Kinetics and prognosis roles of calcitonin after surgery for medullary thyroid carcinoma

文献详情

资源类型:
WOS体系:
Pubmed体系:

收录情况: ◇ SCIE

机构: [1]Tianjin Med Univ Canc Inst & Hosp, Tianjins Clin Res Ctr Canc, Natl Clin Res Ctr Canc, Dept Thyroid & Neck Tumor,Key Lab Canc Prevent & T, Tianjin, Peoples R China [2]Binzhou Med Univ Hosp, Dept Thyroid & Breast Surg, Binzhou, Peoples R China [3]Univ Elect Sci & Technol China, Sichuan Canc Hosp & Inst, Sichuan Canc Ctr, Sch Med,Dept Thyroidotolaryngol, Chengdu, Peoples R China [4]Tianjin Med Univ, Dept Canc Prevent, Canc Inst & Hosp, Tianjin, Peoples R China [5]Tianjin Union Med Ctr, Dept Thyroid & Breast Surg, Tianjin, Peoples R China [6]Tianjin Union Med Ctr, Tianjin Key Lab Gen Surg Construct, Tianjin, Peoples R China
出处:
ISSN:

关键词: Medullary thyroid carcinoma Calcitonin Biochemical persistence Biochemical recurrence Structural recurrence

摘要:
Background Medullary thyroid carcinoma (MTC) is a malignant tumor with low incidence. Currently, most studies have focused on the prognostic risk factors of MTC, whatever, time kinetic and risk factors related to calcitonin normalization (CN) and biochemical persistence/recurrence (BP) are yet to be elucidated. Methods A retrospective study was conducted for 190 MTC patients. Risk factors related to calcitonin normalization (CN) and biochemical persistence/recurrence (BP) were analyzed. The predictors of calcitonin normalization time (CNT) and biochemical persistent/recurrent time (BPT) were identified. Further, the prognostic roles of CNT and BPT were also demonstrated. Results The 5- and 10-year DFS were 86.7% and 70.2%, respectively. The 5- and 10-year OS were 97.6% and 78.8%, respectively. CN was achieved in 120 (63.2%) patients, whereas BP was presented in 76 (40.0%) patients at the last follow up. After curative surgery, 39 (32.5%) and 106 (88.3%) patients achieved CN within 1 week and 1 month. All patients who failed to achieve CN turned to BP over time and 32/70 of them developed structural recurrence. The median time of CNT and BPT was 1 month (1 day to 84 months) and 6 month (3 day to 63months), respectively. LNR > 0.23 and male gender were independent predictors for CN and BP. LNR > 0.23 (Hazard ratio (HR), 0.24; 95% CI,0.13-0.46; P < 0.01) and male gender (HR, 0.65; 95% CI, 0.42-0.99; P = 0.045) were independent predictors for longer CNT. LNR > 0.23 (HR,5.10; 95% CI,2.15-12.11; P < 0.01) was still the strongest independent predictor followed by preoperative serum Ctn > 1400ng/L (HR,2.34; 95% CI,1.29-4.25; P = 0.005) for shorter BPT. In survival analysis, primary tumor size > 2 cm (HR, 5.81; 95% CI,2.20-15.38; P < 0.01), CNT > 1 month (HR, 5.69; 95% CI, 1.17-27.61; P = 0.031) and multifocality (HR, 3.10; 95% CI, 1.45-6.65; P = 0.004) were independent predictor of DFS. Conclusion Early changes of Ctn after curative surgery can predict the long-term risks of biochemical and structural recurrence, which provide a useful real-time prognostic information. LNR significantly affect the time kinetic of biochemical prognosis. Tumor burden and CNT play a crucial role in MTC survival, the intensity of follow-up must be tailored accordingly.

基金:
语种:
WOS:
PubmedID:
中科院(CAS)分区:
出版当年[2023]版:
大类 | 3 区 医学
小类 | 3 区 肿瘤学 3 区 外科
最新[2023]版:
大类 | 3 区 医学
小类 | 3 区 肿瘤学 3 区 外科
JCR分区:
出版当年[2023]版:
Q1 SURGERY Q3 ONCOLOGY
最新[2023]版:
Q1 SURGERY Q3 ONCOLOGY

影响因子: 最新[2023版] 最新五年平均 出版当年[2023版] 出版当年五年平均 出版前一年[2023版]

第一作者:
第一作者机构: [1]Tianjin Med Univ Canc Inst & Hosp, Tianjins Clin Res Ctr Canc, Natl Clin Res Ctr Canc, Dept Thyroid & Neck Tumor,Key Lab Canc Prevent & T, Tianjin, Peoples R China [2]Binzhou Med Univ Hosp, Dept Thyroid & Breast Surg, Binzhou, Peoples R China
共同第一作者:
通讯作者:
通讯机构: [1]Tianjin Med Univ Canc Inst & Hosp, Tianjins Clin Res Ctr Canc, Natl Clin Res Ctr Canc, Dept Thyroid & Neck Tumor,Key Lab Canc Prevent & T, Tianjin, Peoples R China [5]Tianjin Union Med Ctr, Dept Thyroid & Breast Surg, Tianjin, Peoples R China [6]Tianjin Union Med Ctr, Tianjin Key Lab Gen Surg Construct, Tianjin, Peoples R China
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:43377 今日访问量:0 总访问量:3120 更新日期:2024-09-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 四川省肿瘤医院 技术支持:重庆聚合科技有限公司 地址:成都市人民南路四段55号